Want to track UNCY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Unicycive Therapeutics Inc. (UNCY) Statistics
Valuation metrics
Market Cap 109.74M
Enterprise value 66.22M
Trailing P/E (ttm) -2.46
Forward P/E -
PEG ratio -0.03
Price/Sales (ttm) -
Price/Book (mrq) 2.08
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.92
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 551.4K
Average volume (90 days) 704.9K
Price summary
52-Week low 3.35
52-Week high 8.74
Beta -
50-Day moving average 4.11
200-Day moving average 7.2
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 20 Jun 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.49%
Return on equity -0.89%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.31
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.28
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 3.81%
Book value per share (mrq) 1.98
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
